Xavier Michavila
Papers
2
Total Citations
8
H-Index
1
About
Xavier Michavila is a leading thoracic surgeon whose research is reshaping the landscape of minimally invasive lung cancer surgery. His work centers on the comparative effectiveness and safety of robotic-assisted (RATS) versus videothoracoscopic (VATS) lobectomy, with a particular focus on the learning curves and postoperative outcomes associated with each technique. In his highly cited 2024 study, Michavila demonstrated that the learning curve for robotic lobectomy yields better clinical outcomes than VATS, a finding that has significant implications for surgical training and patient care. He has also critically examined the prognostic value of peripheral blood-derived inflammatory indices—such as the neutrophil-lymphocyte ratio and platelet–lymphocyte ratio—in robotic thoracic surgery, concluding they are not reliable predictors for complications. With a growing citation count and a reputation for rigorous, data-driven analysis, Michavila is helping to define the future of lung cancer surgery by providing the evidence needed to optimize surgical approaches and improve patient recovery.
Research Focus
Key Achievements
Top Papers
- 1
- 2